Autoimmune Encephalitis

• CLINICAL_TRIALS trial_result · 2025-12-23
  Clinical Trial Update: Long-term Impact of NMDAR Encephalitis

  A completed clinical trial update examining the long-term outcomes of autoimmune encephalitis associated with NMDA receptor antibodies.

• CLINICAL_TRIALS trial_result · 2025-09-05
  Clinical Trial Update: Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

  Biocells Medical reports ongoing monitoring of outcomes for cellular and exosome-based therapies in autoinflammatory and post-infectious neu…

• CLINICAL_TRIALS trial_result · 2025-08-14
  Clinical Trial Update: Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis [Phase 2]

  Phase 2 trial evaluating adjunctive minocycline with standard care for autoimmune encephalitis has completed, assessing efficacy and safety.

• CLINICAL_TRIALS trial_result · 2025-06-27
  Clinical Trial Update: CPI Combination Therapy for Autoimmune Encephalitis [NA]

  The clinical trial evaluating a CPI combination therapy for autoimmune encephalitis has completed.

• CLINICAL_TRIALS trial_result · 2025-06-26
  Clinical Trial Update: Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis

  This completed trial update reports on the clinical characteristics of patients with anti-Collapsin response mediator protein 2 (CRMP-2) ant…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-01-10
  Clinical Trial Update: Neuro-ophthalmology and Autoimmune Encephalitis (NODE)

  Clinical trial NODE study investigating autoimmune encephalitis with neuro-ophthalmology aspects has completed.

• CLINICAL_TRIALS trial_result · 2022-12-01
  Clinical Trial Update: Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis [Phase 3]

  Phase III clinical study of NPB-01 in autoimmune encephalitis is ongoing with no status available.

• CLINICAL_TRIALS trial_result · 2021-10-19
  Clinical Trial Update: Efficacy of Ocrelizumab in Autoimmune Encephalitis [Phase 2]

  Phase 2 trial assessing efficacy of ocrelizumab in autoimmune encephalitis has been terminated with posted results.

• CLINICAL_TRIALS trial_result · 2020-06-30
  Clinical Trial Update: Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: [Phase 2]

  Phase 2 trial evaluating safety and efficacy of IGIV 10% in autoimmune encephalitis has completed.

• CLINICAL_TRIALS trial_result · 2014-09-01
  Clinical Trial Update: IVIG Treatment for Refractory Immune-Related Adult Epilepsy [Phase 2]

  Phase 2 trial of intravenous immunoglobulin (IVIG) for refractory immune-related epilepsy was terminated. Results have been posted.